C/EBPβ Mediates TNF-α-Induced Cancer Cell Migration by Inducing MMP Expression Dependent on p38 MAPK

Journal of Cellular Biochemistry

Volumn 116, Issue 12, 2015, Pages 2766-2777

  Xia, Peiyi ^a   Zhang, Rui ^a   Ge, Gaoxiang ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

C EBP ; CELL MIGRATION; INFLAMMATION; MMP; p38 MAPK; TNF

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; INTERSTITIAL COLLAGENASE; LAP1 PROTEIN; LAP2 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MMP1 PROTEIN, HUMAN; TNF PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CELL MIGRATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; INFLAMMATION; METABOLISM; NEOPLASM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METASTASIS; PATHOLOGY; PROMOTER REGION; TUMOR CELL LINE;

CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 1; NEOPLASM METASTASIS; NEOPLASMS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84943558436     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25219     Document Type: Article

References (42)

1. Balkwill F,. 2002. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13: 135-141.
2. Balkwill F,. 2006. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 25: 409-416.
3. Balkwill F,. 2009. Tumour necrosis factor and cancer. Nat Rev Cancer 9: 361-371.
4. Bellavance EC, Alexander HR, Jr., 2009. TNF-based isolated hepatic perfusion. Front Biosci (Landmark Ed) 14: 1771-1784.
5. Brouckaert PG, Leroux-Roels GG, Guisez Y, Tavernier J, Fiers W,. 1986. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma. Int J Cancer 38: 763-769.
6. Bundy LM, Sealy L,. 2003. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 22: 869-883.
7. Cabal-Hierro L, Lazo PS,. 2012. Signal transduction by tumor necrosis factor receptors. Cell Signal 24: 1297-1305.
8. Chinery R, Brockman JA, Dransfield DT, Coffey RJ,. 1997. Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299. J Biol Chem 272: 30356-30361.
9. Cho SG, Li D, Stafford LJ, Luo J, Rodriguez-Villanueva M, Wang Y, Liu M,. 2009. KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. J Cell Biochem 107: 1139-1149.
10. Cortez DM, Feldman MD, Mummidi S, Valente AJ, Steffensen B, Vincenti M, Barnes JL, Chandrasekar B,. 2007. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta, NF-kappaB, and AP-1 activation. Am J Physiol Heart Circ Physiol 293: H3356-H3365.
11. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R, Franzoso G,. 2001. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414: 308-313.
12. Ganea E, Trifan M, Laslo AC, Putina G, Cristescu C,. 2007. Matrix metalloproteinases: Useful and deleterious. Biochem Soc Trans 35: 689-691.
13. Gao Y, Xiao Q, Ma H, Li L, Liu J, Feng Y, Fang Z, Wu J, Han X, Zhang J, Sun Y, Wu G, Padera R, Chen H, Wong KK, Ge G, Ji H,. 2010. LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc Natl Acad Sci U S A 107: 18892-18897.
14. Gialeli C, Theocharis AD, Karamanos NK,. 2011. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278: 16-27.
15. Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J,. 2006. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10: 203-214.
16. Grimm SL, Rosen JM,. 2003. The role of C/EBPbeta in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 8: 191-204.
17. Iguchi K, 2012. Effect of bisphosphonates on anticancer activity in prostate cancer cells. Yakugaku Zasshi 132: 1025-1030.
18. Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J,. 2013. MiR-155-mediated loss of C/EBPbeta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene 32:5614-2.
19. Jurisic V, Bogdanovic G, Kojic V, Jakimov D, Srdic T,. 2006. Effect of TNF-alpha on Raji cells at different cellular levels estimated by various methods. Ann Hematol 85: 86-94.
20. Jurisic V, Srdic-Rajic T, Konjevic G, Bogdanovic G, Colic M,. 2011. TNF-alpha induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells. J Membr Biol 239: 115-122.
21. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M,. 2005. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661.
22. Karin M,. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
23. Karin M, Greten FR,. 2005. NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
24. Kitakata H, Nemoto-Sasaki Y, Takahashi Y, Kondo T, Mai M, Mukaida N,. 2002. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. Cancer Res 62: 6682-6687.
25. Kulbe H, Hagemann T, Szlosarek PW, Balkwill FR, Wilson JL,. 2005. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res 65: 10355-10362.
26. LeClair KP, Blanar MA, Sharp PA,. 1992. The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor. Proc Natl Acad Sci U S A 89: 8145-8149.
27. Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL, Chao CH, Yamaguchi H, Yang NK, Ding Q, Wang Y, Lai YJ, LaBaff AM, Wu TJ, Lin BR, Yang MH, Hortobagyi GN, Hung MC,. 2012. Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer Res 72: 1290-1300.
28. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M,. 2004. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6: 297-305.
29. Malik ST, Naylor MS, East N, Oliff A, Balkwill FR,. 1990. Cells secreting tumour necrosis factor show enhanced metastasis in nude mice. Eur J Cancer 26: 1031-1034.
30. Miura Y, Hagiwara N, Radisky DC, Hirai Y,. 2014. CCAAT/enhancer binding protein beta (C/EBPbeta) isoform balance as a regulator of epithelial-mesenchymal transition in mouse mammary epithelial cells. Exp Cell Res 327: 146-155.
31. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S,. 1993. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci U S A 90: 2207-2211.
32. Orosz P, Echtenacher B, Falk W, Ruschoff J, Weber D, Mannel DN,. 1993. Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med 177: 1391-1398.
33. Orosz P, Kruger A, Hubbe M, Ruschoff J, Von Hoegen P, Mannel DN,. 1995. Promotion of experimental liver metastasis by tumor necrosis factor. Int J Cancer 60: 867-871.
34. Park BH, Kook S, Lee S, Jeong JH, Brufsky A, Lee BC,. 2013. An isoform of C/EBPbeta, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration. J Biol Chem 288: 28656-28667.
35. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV,. 1984. Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312: 724-729.
36. Szlosarek PW, Balkwill FR,. 2003. Tumour necrosis factor alpha: A potential target for the therapy of solid tumours. Lancet Oncol 4: 565-573.
37. Tsukada J, Yoshida Y, Kominato Y, Auron PE,. 2011. The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 54: 6-19.
38. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R,. 2002. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
39. Wang Y, Singh R, Xiang Y, Greenbaum LE, Czaja MJ,. 2010. Nuclear factor kappaB up-regulation of CCAAT/enhancer-binding protein beta mediates hepatocyte resistance to tumor necrosis factor alpha toxicity. Hepatology 52: 2118-2126.
40. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, Zhou BP,. 2009. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15: 416-428.
41. Zahnow CA, 2009. CCAAT/enhancer-binding protein beta: Its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev Mol Med 11: e12.
42. Zhu X, Wang Z, Hu C, Li Z, Hu J,. 2014. Honokiol suppresses TNF-alpha-induced migration and matrix metalloproteinase expression by blocking NF-kappaB activation via the ERK signaling pathway in rat aortic smooth muscle cells. Acta Histochem 116: 588-595.